4//SEC Filing
RAPP MICHAEL 4
Accession 0001209191-20-054318
CIK 0001472012other
Filed
Oct 7, 8:00 PM ET
Accepted
Oct 8, 6:16 PM ET
Size
14.2 KB
Accession
0001209191-20-054318
Insider Transaction Report
Form 4
Immunome Inc.IMNM
RAPP MICHAEL
Director10% Owner
Transactions
- Conversion
Series A Convertible Preferred Stock
2020-10-06−555,554→ 0 total→ Common Stock (555,554 underlying) - Conversion
Warrant (right to buy)
2020-10-06−166,666→ 0 totalExercise: $9.00Exp: 2023-06-02→ Series A Convertible Preferred Stock (166,666 underlying) - Conversion
Warrant (right to buy)
2020-10-06+166,666→ 166,666 totalExercise: $9.00Exp: 2023-06-02→ Common Stock (166,666 underlying) - Purchase
Common Stock
2020-10-06$12.00/sh+83,332$999,984→ 638,886 total - Conversion
Common Stock
2020-10-06+555,554→ 555,554 total
Holdings
- 827,640(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]Each share of Series A Convertible Preferred Stock automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date.
- [F2]The shares are held by BCM Advisory Partners LLC (the "LLC"). The Reporting Person is a managing member of the LLC and has voting and investment power with respect to shares held by the LLC.
- [F3]Each share of Series A Convertible Preferred Stock underlying this warrant automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date.
- [F4]Immediately exercisable.
Documents
Issuer
Immunome Inc.
CIK 0001472012
Entity typeother
Related Parties
1- filerCIK 0001405685
Filing Metadata
- Form type
- 4
- Filed
- Oct 7, 8:00 PM ET
- Accepted
- Oct 8, 6:16 PM ET
- Size
- 14.2 KB